JBP 485

Drug Profile

JBP 485

Alternative Names: JBP-485

Latest Information Update: 05 Feb 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of Tokyo
  • Developer Japan Bioproducts Industry Company; University of Tokyo
  • Class Dipeptides; Hepatoprotectants
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hepatitis; Liver disorders

Most Recent Events

  • 27 Jan 2004 No development reported - Preclinical for Hepatitis in Japan (unspecified route)
  • 27 Jan 2004 No development reported - Preclinical for Liver disorders prevention in Japan (unspecified route)
  • 05 Sep 2001 Preclinical development for Hepatitis in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top